MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Cognitive-motor tests markedly increase the diagnostic rate of “On-meds” freezing of gait in Parkinson’s disease during clinical visits

    Z. Pei (Guangzhou, China)

    Objective: To develop a testing and recording system that can reliably increase the rate of diagnosing freezing of gait (FOG) in patients living with Parkinson’s…
  • 2022 International Congress

    Common mistakes in the MoCA test in patients with Parkinson’s Disease in Kyrgyzstan

    A. Il'Yazova, C. Shambetova, E. Zhunusova (Bishkek, Kyrgyzstan)

    Objective: The aim of the study is to identify common mistakes in MoCA in patients with Parkinson’s disease (PD) in Kyrgyzstan. Background: Cognitive impairment is…
  • 2022 International Congress

    Changes in anticholinergic burden in patients with Parkinson’s disease (PD) after bilateral deep brain stimulation (DBS) of the globus pallidus (GP) and subthalamic nucleus (STN)

    J. Jiao, M. Wilheimi, B. Brumbach, D. Safarpour (Portland, USA)

    Objective: To evaluate the effect of GP and STN DBS upon anticholinergic medication burden in patients with PD. Background: Medications with anticholinergic effects are commonly…
  • 2022 International Congress

    The level of glial neurotrophic factor in blood plasma depending on the stage of Parkinson’s disease

    R. Matmurodov, M. Muminov, A. Abduqodirov, K. Khalimova (Tashkent, Uzbekistan)

    Objective: To study the level of glial neurotrophic disease in blood plasma in patients with Parkinson's disease (PD) depending on the stage Background: Parkinson's disease…
  • 2022 International Congress

    Deep learning applied to retinal OCT images to differentiate Parkinson’s disease patients from healthy controls

    M. Barrenechea, D. Romero-Bascones, A. Murueta-Goyena, JC. Gomez-Esteban, A. Alberdi, A. Erramuzpe, U. Ayala, I. Gabilondo (Mondragon, Spain)

    Objective: This study aims to investigate the capability of artificial intelligence, more precisely deep convolutional neural networks (CNN), to automatically classify between healthy controls (HC)…
  • 2022 International Congress

    A One-year follow-up study of effects of voltage/frequency Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) adjustments on speech intelligibility in Parkinson’s Disease (PD)

    N. Castillo-Triana, M. Camargo-Mendoza, O. Bernal-Pacheco (Bogotá, Colombia)

    Objective: To assess the relationship between along-1-year stimulation voltage(V)/frequency(F) adjustments and speech intelligibility (SI) in PD patients treated with STN-DBS. Background: Low V/F stimulation improves…
  • 2022 International Congress

    New-onset gait problems after bilateral STN-DBS for Parkinson’s disease: A systematic review

    J. Janssen Daalen, A. Selvaraj, D. Georgiev, B. Bloem, R. Bartels, R. Esselink, S. Vinke (Nijmegen, Netherlands)

    Objective: In this systematic review, we provide an overview of an underrecognized, but common side effect related to deep brain stimulation of the subthalamic nucleus…
  • 2022 International Congress

    Subthalamic beta bursts reflect the continuous stochastic fluctuations of ongoing oscillations in Parkinson’s disease

    J. Pardo-Valencia, C. Fernández-García, F. Alonso-Frech, G. Foffani (Móstoles, Spain)

    Objective: To test whether subthalamic beta bursts in Parkinson’s disease reflect the continuous stochastic fluctuations of an oscillatory random process. Background: Subthalamic beta oscillations in…
  • 2022 International Congress

    Low-dose lithium therapy associated with increased PBMC Nurr1 and SOD1 expression in Parkinson’s disease: a pilot study.

    T. Guttuso, JR., R. Shepherd, M. Tamano, M. Ramanathan, V. Frerichs, L. Frick (Williamsville, USA)

    Objective: To determine the effects of lithium therapy on blood-based biomarkers in Parkinson’s disease (PD). Background: Lithium has multiple neuroprotective actions and may account for…
  • 2022 International Congress

    Feasibility of in-person and remote delivery of Alexander technique course for care partners of people with neurodegenerative disease

    M. Gross, R. Cohen, J. Bellingham, P. Brisset, C. Condie, S. Lazaro, B. Mello, A. Abdelrahman, J. Becker, S. Smith, T. Moote, W. Trusty (Candler, USA)

    Objective: Test feasibility of in-person and remote delivery via Zoom of Alexander technique (AT) course to improve quality of life for care partners (CP) of…
  • « Previous Page
  • 1
  • …
  • 213
  • 214
  • 215
  • 216
  • 217
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley